From dietary lignans to cancer therapy: Integrative systems analysis of enterolactone's molecular targets and signaling pathways in combatting cancer stem cells in …
Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by resistance
to conventional treatments and high recurrence rates. Cancer stem cells (CSCs) within …
to conventional treatments and high recurrence rates. Cancer stem cells (CSCs) within …
Matairesinol repolarizes M2 macrophages to M1 phenotype to induce apoptosis in triple-negative breast cancer cells
A Chaudhary, P Patil, P Raina… - Immunopharmacology …, 2024 - Taylor & Francis
Abstract Objective Triple-Negative Breast Cancer (TNBC), the most challenging subtype of
Breast Cancer (BC), currently lacks targeted therapy, presenting a significant therapeutic …
Breast Cancer (BC), currently lacks targeted therapy, presenting a significant therapeutic …
A multitier virtual screening of antagonists targeting PD-1/PD-L1 interface for the management of triple-negative breast cancer
HNR Krishnamoorthy, R Karuppasamy - Medical Oncology, 2023 - Springer
Immunotherapies are promising therapeutic options for the management of triple-negative
breast cancer because of its high mutation rate and genomic instability. Of note, the …
breast cancer because of its high mutation rate and genomic instability. Of note, the …
[HTML][HTML] Decreased Expression of CD247 and CD4 Immune Marker Predicts Poor Prognosis in Triple Negative Breast Cancer
A Pateriya, R Nema, AK Mishra… - … Pacific Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Objective: Triple negative breast cancer (TNBC) is an aggressive from of breast cancer and
is associated with poor prognosis. Tumor microenvironment of breast cancer consists of a …
is associated with poor prognosis. Tumor microenvironment of breast cancer consists of a …
Avaliação da relação entre linfócitos infiltrantes e resposta inflamatória no câncer de mama: Uma revisão sistemática
JM Gomes, EA Esper, AA Ribeiro - Research, Society and …, 2023 - rsdjournal.org
Breast cancer is the most incident type of cancer in women worldwide and delays in its
diagnosis and treatment potentially reduce survival rates. It is a heterogeneous disease and …
diagnosis and treatment potentially reduce survival rates. It is a heterogeneous disease and …
[PDF][PDF] Molecular subtypes of cancer-associated fibroblasts and their regulation of the tumour microenvironment in pancreatic ductal adenocarcinoma.
A Hussain - 2024 - repository.icr.ac.uk
Pancreatic Ductal Adenocarcinoma (PDAC) remains a leading cause of cancer-related
deaths, with a 5-year survival rate of less than 10% in Western countries. Transcriptomic …
deaths, with a 5-year survival rate of less than 10% in Western countries. Transcriptomic …
[PDF][PDF] UNIDAD MÉDICA DE ALTA ESPECIALIDAD HOSPITAL DE GINECO OBSTETRICIA No. 4 “LUIS CASTELAZO AYALA”
EDEMUEN FETOS - 2023 - ru.dgb.unam.mx
Antecedentes: La hiperglucemia es uno de los problemas médicos más comunes asociados
con el embarazo. La aparición de diabetes mellitus gestacional (DMG) y diabetes mellitus …
con el embarazo. La aparición de diabetes mellitus gestacional (DMG) y diabetes mellitus …